Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2026-02-25 @ 9:44 PM
Study NCT ID:
NCT04982393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2021-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Sponsor:
Alnylam Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-20
First Submit QC Date:
None
Study First Post Date:
2021-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL